Suchergebnisse - "van de Donk, Niels W C J"

PubPharm (93)

1

CD38-targeted therapy with daratumumab reduces autoantibody levels in multiple myeloma patients

enthalten in: Journal of translational autoimmunity | 2019

von Frerichs, K. | Verkleij, C. | Bosman, P. | +3

2

Subcutaneous delivery of daratumumab in relapsed or refractory multiple myeloma

enthalten in: Blood | 2019

von Usmani, S. | Nahi, H. | Mateos, M. | +13

3

Combined CD28 and 4-1BB Costimulation Potentiates Affinity-tuned Chimeric Antigen Receptor-engineered T Cells

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2019

von Drent, E. | Poels, R. | Ruiter, R. | +9

4

CD38 as a therapeutic target for adult acute myeloid leukemia and T-cell acute lymphoblastic leukemia

enthalten in: Haematologica | 2019

von Naik, J. | Themeli, M. | de Jong-Korlaar, R. | +11

5

High-Parameter Mass Cytometry Evaluation of Relapsed/Refractory Multiple Myeloma Patients Treated with Daratumumab Demonstrates Immune Modulation as a Novel Mechanism of Action

enthalten in: Cytometry. Part A : the journal of the International Society for Analytical Cytology | 2019

von Adams, H. | Stevenaert, F. | Krejcik, J. | +16

CommentIn: Cytometry A. 2019 Apr;95(4):416-418. - PMID 30908843

6

Impact of Fc gamma receptor polymorphisms on efficacy and safety of daratumumab in relapsed/refractory multiple myeloma

enthalten in: British journal of haematology | 2019

von van de Donk, N. | Casneuf, T. | Di Cara, A. | +11

7

Insights on Multiple Myeloma Treatment Strategies

enthalten in: HemaSphere | 2019

von Mateos, M. | Ludwig, H. | Bazarbachi, A. | +24

8

Reprint of "Immunomodulatory effects of CD38-targeting antibodies"

enthalten in: Immunology letters | 2019

von van de Donk, N.

ReprintOf: Immunol Lett. 2018 Jul;199:16-22. - PMID 29702148

9

Oral proteasome inhibitor maintenance for multiple myeloma

enthalten in: Lancet (London, England) | 2019

von van de Donk, N. | Yong, K.

CommentOn: Lancet. 2019 Jan 19;393(10168):253-264. - PMID 30545780

10

Immunotherapy in myeloma : how far have we come?

enthalten in: Therapeutic advances in hematology | 2019

von Franssen, L. | Mutis, T. | Lokhorst, H. | +1

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]